Eurofins Genomics, part of the international life sciences group Eurofins Scientific, provides high-quality products to serve the genomics industry and support advanced drug development and manufacture. Eurofins Genomics provides custom oligonucleotides with hundreds of modification options, specialized long RNA oligos, both sanger and nanopore sequencing, gene synthesis, and IVT mRNA synthesis products and services. Eurofins Genomic is headquartered in Louisville, Kentucky, with additional North American offices in Ontario and British Columbia, Canada.